IRWD
Ironwood Pharmaceuticals Inc
Price:  
9.07 
USD
Volume:  
15,931,332.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD EV/EBITDA

39.9%
Upside

As of 2024-03-04, the EV/EBITDA ratio of Ironwood Pharmaceuticals Inc (IRWD) is 11.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IRWD's latest enterprise value is 2,024.66 mil USD. IRWD's TTM EBITDA according to its financial statements is 169.91 mil USD. Dividing these 2 quantities gives us the above IRWD EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.4x - 16.5x 13.3x
Forward P/E multiples 14.7x - 19.8x 17.2x
Fair Price 9.57 - 17.64 12.68
Upside 5.6% - 94.6% 39.9%
9.07 USD
Stock Price
12.68 USD
Fair Price

IRWD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 12.26
2024-03-01 11.92
2024-02-29 12.25
2024-02-28 17.49
2024-02-27 17.55
2024-02-26 17.41
2024-02-23 17.45
2024-02-22 17.25
2024-02-21 17.51
2024-02-20 17.23
2024-02-16 17.00
2024-02-15 17.37
2024-02-14 17.80
2024-02-13 17.57
2024-02-12 17.72
2024-02-09 17.68
2024-02-08 17.29
2024-02-07 17.26
2024-02-06 17.26
2024-02-05 17.15
2024-02-02 17.01
2024-02-01 17.02
2024-01-31 16.64
2024-01-30 16.28
2024-01-29 16.24
2024-01-26 15.90
2024-01-25 16.05
2024-01-24 15.83
2024-01-23 15.98
2024-01-22 15.67
2024-01-19 15.24
2024-01-18 14.79
2024-01-17 14.95
2024-01-16 14.38
2024-01-12 14.76
2024-01-11 14.84
2024-01-10 15.03
2024-01-09 15.09
2024-01-08 15.32
2024-01-05 15.03
2024-01-04 15.00
2024-01-03 14.91
2024-01-02 15.00
2023-12-29 14.10
2023-12-28 14.13
2023-12-27 14.17
2023-12-26 13.95
2023-12-22 13.86
2023-12-21 13.79
2023-12-20 13.70